For US Healthcare Professionals
|
|
|
Patients should read this information before they start taking a product and each time they refill their prescription, in case any information has changed.
This provides only a summary of certain information about the product. It does not take the place of careful discussions between patients and their doctors.
|
COZAAR® (losartan potassium tablets)
(See Boxed Warning on use in pregnancy in Prescribing Information)
|
|
EMEND® (fosaprepitant dimeglumine) for Injection
|
|
HYZAAR® (losartan potassium-hydrochlorothiazide tablets)
(See Boxed Warning on use in pregnancy in Prescribing Information)
|
|
JANUMET® (sitagliptin/metformin HCl) tablets
(Please read the Boxed Warning about lactic acidosis in the Prescribing Information.)
|
|
MAXALT® (rizatriptan benzoate) Tablets
|
|
MAXALT-MLT® (rizatriptan benzoate) Orally Disintegrating Tablets
|
|
|
|
Merck/Schering-Plough Pharmaceuticals |
VYTORIN® (ezetimibe/simvastatin) Tablets
|
|
ZETIA® (ezetimibe) Tablets
|
|
|
This is not a complete list of Merck products. For a full listing of Merck products, please visit Prescribing Information for all Merck Products.
|
|
|
Ask a Product-Related Question or Report an Adverse Event
Let us assist you with information and services related to Merck and its products.
Get Started
The Merck National Service Center will be pleased to assist you Monday–Friday from 8:00 AM–7:00 PM ET. Adverse events and product-related emergencies will be handled at any time.
|
|
All product names listed on this site are registered trademarks owned by or licensed to a subsidiary of Merck & Co., Inc.
MerckProductServices, MerckServices, MerckSource, Merck OnCall, MerckMedicus, and MerckEngage are trademarks or registered trademarks of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
COZAAR and HYZAAR are registered trademarks of E.I. du Pont de Nemours and Company, Wilmington, Delaware, USA
|
|
|
|
